Lasmiditan is associated with greater odds of achieving pain freedom from migraine attacks compared with placebo.
A pooled analysis evaluated reductions in migraine and headache days among patients with chronic migraine and comorbid depression in 2 placebo-controlled, phase 3 trials of fremanezumab.
Connectivity between the amygdala and specific brain regions may predict headache reduction after cognitive behavioral therapy for adolescent migraine.
Migraine has a considerable impact on women’s pregnancy plans, with about 20 percent avoiding pregnancy due to migraine.
The goal of the current study was to assess the potential role of anxiety and depression on pain catastrophizing in older adults with chronic pain.
The FDA reported that between July 27, 2016 and July 27, 2020, a total of 107,728 medical device reports (MDRs) associated with SCS devices intended for pain were received.
Qdolo contains tramadol, an opioid agonist and inhibitor of norepinephrine and serotonin reuptake.
Among patients with multiple sclerosis, a history of migraine may not be associated with worse disability or neurological function.
Patients with MS treated with peginterferon beta-1a or intramuscular interferon beta 1a may experience real world treatment benefits.
Patients with neuromyelitis optica spectrum disorder who experience relapses use more pain medication than non-relapsing patients.